share_log

Bristol Myers Squibb Announces Opdivo plus Chemotherapy Demonstrated A Statistically Significant And Clinically Meaningful Benefit For The Primary And Secondary Endpoints Of Overall Survival; Co. Repo

Bristol Myers Squibb Announces Opdivo plus Chemotherapy Demonstrated A Statistically Significant And Clinically Meaningful Benefit For The Primary And Secondary Endpoints Of Overall Survival; Co. Repo

百时美施贵宝公司宣布Opdivo加化疗显示出对总存活率的主要和次要终点有统计意义和临床意义的益处；Repo公司
Benzinga Real-time News ·  2021/04/08 19:00

Bristol Myers Squibb Announces Opdivo plus Chemotherapy Demonstrated A Statistically Significant And Clinically Meaningful Benefit For The Primary And Secondary Endpoints Of Overall Survival; Co. Reports Opdivo Plus Yervoy Also Met Its Primary Endpoint

百时美施贵宝公司宣布Opdivo Plus化疗显示出对总存活率的主要和次要终点有统计意义和临床意义的益处；公司报告Opdivo Plus Yervoy也满足其主要终点

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发